
Department: GCP Quality, Syngene International Ltd.
Location: Translational Health Science and Technology Institute (THSTI) - Faridabad, Haryana, India.
About Syngene: Syngene is seeking a seasoned professional to manage its GCP quality function at THSTI Faridabad, Haryana on behalf of Syngene GCP Quality Organisation. He/she is responsible for building and scaling Quality Management Systems implementation programs and developing Quality assurance systems and implement QA oversight for clinical First-In Human (FIH) / Phase I studies and related activities. This QA Manager role is pivotal in quality and compliance oversight on clinical operations at the THSTI clinical research facility with the latest skills and knowledge to meet evolving client expectations and national and international regulatory standards and requirements.
Core Purpose of the Role: The GCP QA Sr.Manager-Clinical is responsible for managing the GCP QA audit management and auditors team and to perform the study-based audits, process audits, clinical and safety database audits, and assess the systems and practices for improving the GCP Quality System practices independently and shall consult with GCP Quality Head as required by Syngene International Ltd, Corporate Quality Policies.
This GCP QA Sr.Manager must be comfortable exercising latitude in ensuring the Syngene’ s Translational & Clinical Research (T&CR) MOU collaboration unit at THSTI clinical research facility is compliant with the national and international GCP Quality System, the quality (GxP) regulations and standards it is built on and ultimately is audit /inspection ready to have good outcome.
Comfortable working and communicating professionally with others to reach understanding and agreement as necessary.
All employees will consistently demonstrate alignment with our core values
Education: M. Pharm in Pharmacology Or QA / M.Sc. or M. Tech in Basic Medical Sciences/ Life Sciences/Biotechnology.
Equal Opportunity Employer: It is the policy of Syngene to provide equal employment opportunity (EEO) to all persons regardless of age, color, national origin, citizenship status, physical or mental disability, race, religion, creed, gender, sex, sexual orientation, gender identity and/or expression, genetic information, marital status, status with regard to public assistance, veteran status, or any other characteristic protected by applicable legislation or local law. In addition, Syngene will provide reasonable accommodations for qualified individuals with disabilities.

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
Syngene's more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.
With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA.
For more details, visit www.syngeneintl.com or write to us at bdc@syngeneintl.com